Our approach utilizes the high recombination efficiency in yeast which permits the insertion of genetic markers at precise chromosomal positions by gene replacement (1,2). Typically, yeast cells are transformed with a replication incompetent DNA fragment containing a marker gene flanked by sequences homologous to the integration site, which promote two homologous recombination events. To adopt this strategy for our purposes, a mouse gene segment of >7 kb which provides the backbone of a targeting vector for ES cells, isolated from a λ genomic library, is cloned in an Escherichia coli/yeast shuttle vector. In parallel, all GEs to be inserted into the gene segment, including the neo gene and the yeast selection marker URA3, are assembled by cloning into a suitable bacterial plasmid (e.g. the pRAY vectors described below and in Fig. 1) . The GEs are then collectively flanked by short (200-400 bp) sequences, PCR-derived from a location in the mouse gene segment where GE insertion is desired. These short sequences which direct GE insertion are termed recombinogenic arms (RAs). Finally, to transfer the GEs into the gene segment on the shuttle vector, the entire GE cassette flanked by RAs is released from the bacterial vector and transfected as donor DNA into yeast cells together with the recombinant shuttle vector as the recipient (Fig. 1) . Homologous recombinants are selected by URA and plasmids from selected colonies are then transferred to E.coli. Transfer to E.coli is necessary because not all copies of the recombinant shuttle vector in a yeast cell undergo homologous recombination. It also facilitates plasmid growth for further DNA analysis. In our experiments (Table 1) , yeast strain DF5 (3) was co-transformed by lithium acetate (4) with 500 ng each of the shuttle vector YCplac22 (5) containing gene segments of ∼7 kb and of donor DNA flanked by 200-400 bp RAs of sequence identity (or near identity if containing point mutations) to the particular mouse gene segment in the shuttle vector. Typically, out of 4000 Trp + transformants, 30-50 survived URA selection. In all survivors, the GEs including URA3 were inserted via homologous recombination at the selected position, as determined by DNA sequencing and restriction analysis (see below). Using this procedure, we targeted into gene segments GEs ranging from 1 to 5 kb and also introduced point mutations simultaneously via the RAs. The recombination frequency in these experiments was ∼1% (Table 1) . This efficiency was reduced with RAs of only 25 bp in length, and no recombinants were obtained when these 25 bp RAs carried short, non-homologous 5′ extensions from a polylinker (Table 1) .
Our approach utilizes the high recombination efficiency in yeast which permits the insertion of genetic markers at precise chromosomal positions by gene replacement (1, 2) . Typically, yeast cells are transformed with a replication incompetent DNA fragment containing a marker gene flanked by sequences homologous to the integration site, which promote two homologous recombination events. To adopt this strategy for our purposes, a mouse gene segment of >7 kb which provides the backbone of a targeting vector for ES cells, isolated from a λ genomic library, is cloned in an Escherichia coli/yeast shuttle vector. In parallel, all GEs to be inserted into the gene segment, including the neo gene and the yeast selection marker URA3, are assembled by cloning into a suitable bacterial plasmid (e.g. the pRAY vectors described below and in Fig. 1) . The GEs are then collectively flanked by short (200-400 bp) sequences, PCR-derived from a location in the mouse gene segment where GE insertion is desired. These short sequences which direct GE insertion are termed recombinogenic arms (RAs). Finally, to transfer the GEs into the gene segment on the shuttle vector, the entire GE cassette flanked by RAs is released from the bacterial vector and transfected as donor DNA into yeast cells together with the recombinant shuttle vector as the recipient (Fig. 1) . Homologous recombinants are selected by URA and plasmids from selected colonies are then transferred to E.coli. Transfer to E.coli is necessary because not all copies of the recombinant shuttle vector in a yeast cell undergo homologous recombination. It also facilitates plasmid growth for further DNA analysis. In our experiments (Table 1) , yeast strain DF5 (3) was co-transformed by lithium acetate (4) with 500 ng each of the shuttle vector YCplac22 (5) containing gene segments of ∼7 kb and of donor DNA flanked by 200-400 bp RAs of sequence identity (or near identity if containing point mutations) to the particular mouse gene segment in the shuttle vector. Typically, out of 4000 Trp + transformants, 30-50 survived URA selection. In all survivors, the GEs including URA3 were inserted via homologous recombination at the selected position, as determined by DNA sequencing and restriction analysis (see below). Using this procedure, we targeted into gene segments GEs ranging from 1 to 5 kb and also introduced point mutations simultaneously via the RAs. The recombination frequency in these experiments was ∼1% (Table 1) . This efficiency was reduced with RAs of only 25 bp in length, and no recombinants were obtained when these 25 bp RAs carried short, non-homologous 5′ extensions from a polylinker ( The columns show from left to right the number of independent experiments, the recipient recombinant shuttle vector, the donor DNAs with the length (bp) of 5′-RAs, GEs and 3′-RAs, the sequence length in the mouse gene segment replaced by the GEs (0 bp, insertion), and the frequency of homologous recombination expressed as % transformants. Cotransformation of yeast (for details see text) was with different donor DNAs and two recombinant shuttle vectors, YCplac22a and YCplac22b, each containing a different mouse gene segment (7.0 and 7.3 kb, respectively). The GEs consisted of combinations of the URA3 marker, neo, and several transcriptional control elements, except for experiments 5 and 6 in which URA3 was the only GE. Donor DNA was assembled in and released from pRAY-1 (experiments1-3), from pRAY-2 (see text, experiment 4) or was entirely PCR-derived (experiments 5 and 6). Experiments 5 and 6 differ in that the 25 bp RAs in the latter additionally contain a NotI-generated overhang at both ends which was generated by cloning and excising this donor DNA from a plasmid. No rearrangement of mouse gene segments was observed in the recombined targeting vectors, since restriction patterns of recombinant shuttle vectors did not change after growth in yeast for 48 generations (data not shown). Recombined targeting vectors grown in E.coli were further identified by comparison of restriction patterns with the genomic clone ( Fig. 2) and by sequence analysis of the DNA flanking the introduced GEs (not shown). In all cases examined, the GEs had been inserted precisely as predicted.
To facilitate the cloning steps involved in the assembly of GEs and RAs, we designed the vector pRAY-1 (Fig. 1B) which carries the URA3 gene and the neo selection marker for later use in ES cells. The dual selection box is flanked by four unique restriction sites for the insertion of GEs and RAs, and by loxP elements which permit Cre recombinase-mediated removal (6) of the selection genes after successful targeting. SfiI-NotI release of the donor DNA from pRAY-1 leaves at the very ends of the RAs a few base pairs, that are not homologous to targeted sequences. With RAs of >200 bp, these non-homologous termini did not interfere with homologous recombination by which they were removed, as revealed by DNA sequence analysis.
To provide an alternative for the URA selection in yeast, we constructed the vector pRAY-2 which lacks the URA3 gene but contains a neo gene modified to confer resistence to E.coli as well as ES cells (7) . After cotransformation into yeast with 500 ng of recombinant shuttle vector and 500 ng of donor DNA from pRAY-2, plasmid DNA prepared from ∼2000 pooled Trp + colonies was electroporated into E.coli strain XL1Blue (Stratagene). Approximately 10 bacterial transformants harbouring the recombined targeting vector could be selected on agar plates containing 15 µg/ml kanamycin (Table 1) . Thus, the pRAY vectors provide selection markers for the recombination event either in yeast (URA3) or in E.coli (neo). Moreover, due to the high efficiency of homologous recombination (∼1% with RAs of >200 bp), yeast tranformants can be screened directly by PCR for the successful targeting, precluding the use of a selection marker in the donor DNA.
The use of homologous recombination in yeast for the targeted insertion of GEs in a large mouse gene segment is in accordance with the widely used recombination strategy for targeting yeast genes (1,2) and for manipulating (8, 9) or rescuing (10) genes cloned in yeast artificial chromosomes. The method proved advantageous in our hands for the construction of several complex gene targeting vectors, each within 3 weeks which compares favorably with the several months required for bacterial cloning. It should be of general use for manipulating DNA sequences without taking recourse to suitable restriction sites.
